Sanofi is changing the organizational structure of two of its Global Business Units (GBU) in an effort to provide greater focus on its operations in mature markets and across emerging markets.
The company will create a new Primary Care GBU that combines the product portfolios of Sanofi’s existing Diabetes and Cardiovascular (DCV) GBU with Established Products, which are currently part of the General Medicines & Emerging Markets (GEM) GBU.  The new Primary Care unit will focus exclusive...